Concepedia

Publication | Closed Access

Dabigatran etexilate as second-line therapy in patients with a left ventricular assist device.

44

Citations

27

References

2015

Year

John Terrovitis, Argyrios Ntalianis, Chris J. Kapelios, Styliani Vakrou, Nikolaos Diakos, Lambros Katsaros, Michalis Tsamatsoulis, Elisabeth Kaldara, Christos Charitos, John N. Nanas
PubMed

Abstract

The safe and effective use of dabigatran as a second-line anticoagulation therapy in patients with HMII seems feasible. However, these data must be confirmed in a randomized study.

References

YearCitations

Page 1